Go to Page # Page of 51

Stroke Prevention - The Intersection of Cardiology & Neurology

 Michael R.K. Jacoby MD
Description: Dyslipidemia: - Statin therapy if significant 10-year stroke risk. Nonstatins if statins not tolerated but no established efficacy. Other Cardiac: - Mitral stenosis with embolic event– Anticoagulation. Mitral stenosis with LA thrombus – Anticoagulation. Aortic mechanical valve – Warfarin (INR 2-3) + aspirin 81 mg, With risk factors (INR 2.5-3.5) +ASA 81 mg. Other mechanical valves (INR 2.5-3.5)+ASA 81 mg.
Views: 680
Domain: Medical
Category: Therapy
Contributing Organization: Iowa Heart Foundation
 ‐ More of their Presentations
LithoVision 2018
Stroke Prevention 2016

Intersection of Cardiology & Neurology
Summary of Recommendations
Michael R.K. Jacoby, MD, FAHA
Medical Director, Mercy Stroke Center

Stroke Disclosures
•  Speaker for Boehringer-Ingelheim

Stroke 2016
Summary of Recommendations
•  American Stroke Association
•  American Heart Association
•  American Academy of Neurology
... See more

Recent Presentations

Jefferies LLC.
16 January, 2018

Design to value in medical devices

If medical device companies want to continue to make money as prices face continued pressure, their only option is to take cost out.” This comment from the head of procurement at a

15 January, 2018
Web Japan
14 January, 2018